Document:

Exhibit 10.6

 

PLACEMENT AGENCY AGREEMENT

 

April 17, 2015

 

	
        

        Northland Securities, Inc.
	Katalyst Securities LLC
	Mr. Jeffrey Peterson, Director	Mr. Paul Ehrenstein, President
	45 S. 7th Street, Suite 2000	15 Maiden Lane, Suite 601
	Minneapolis, MN  55402	New York, NY  10038

 

Re:         Danlax Corp. (to be renamed Akoustis
Technologies, Inc.)

 

Dear Mr. Peterson and Mr. Ehrenstein:

 

This Placement Agency
Agreement (“Agreement”) sets forth the terms upon which Northland Securities, Inc. (“Northland”) and Katalyst
Securities, LLC (“Katalyst”), registered broker-dealers and members of the Financial Industry Regulatory Authority
(“FINRA”), (hereinafter referred to as the “Placement Agents”), shall be engaged by Danlax Corp. (to be
renamed Akoustis Technologies, Inc., a publicly traded Nevada Corporation (hereinafter referred to as the “Company”),
to act as exclusive co-Placement Agents in connection with the private placement (the “Offering”) of the securities
of the Company (the “Securities”). The initial closing of the Offering will be conditioned upon and acceptance of subscriptions
for the Minimum Amount (as defined below) and the consummation of a reverse triangular merger (the “Merger”) by and
among a subsidiary of the Company, Akoustis, Inc., (“Akoustis”), a privately held Delaware corporation, and the Company
and certain other transactions describe herein, pursuant to which Akoustis will become a wholly owned subsidiary of the Company,
and all of the outstanding Akoustis stock will be converted into shares of the Company’s common stock.

 

1.            Appointment
of Placement Agents.

 

(a)          On
the basis of the written and documented representations and warranties of the Company provided herein, and subject to the terms
and conditions set forth herein, the Placement Agents are hereby appointed as co-exclusive Placement Agents of the Company during
the Offering Period (as defined in Section 3(b) below) to assist the Company in finding qualified subscribers for the Offering.
The Placement Agents may sell the Securities through other broker-dealers who are FINRA members (collectively, the “Sub Agents”)
and may reallow all or a portion of the Brokers’ Fees (as defined in Section 3(a), 3(b) and 3(d) below) it receives to such
other Sub Agents or pay a finders or consultant fee as allowed by applicable law. On the basis of such representations and warranties
and subject to such terms and conditions, the Placement Agents hereby accept such appointment and agree to perform the services
hereunder diligently and in good faith and in a professional and businesslike manner and in compliance with applicable law and
to use its reasonable best efforts to assist the Company in finding subscribers of the Securities who qualify as “accredited
investors,” as such term is defined in Rule 501 of Regulation D. The Placement Agents have no obligation to purchase any
of the Securities or sell any Securities. Unless sooner terminated in accordance with this Agreement, the engagement of the Placement
Agents hereunder shall continue until the later of the Termination Date or the Final Closing (as defined below). The Offering is
currently anticipated to be the private placement of a minimum of gross proceeds of $3,000,000 (the “Minimum Offering”)
and a maximum of gross proceeds of $6,000,000 (the “Maximum Offering”) through the sale of shares of common stock,
par value $0.001 per share, of the Company (the “Common Stock”), at the Purchase Price of $1.50 per share (the “Offering
Price”). The minimum subscription is $90,000 (60,000 shares), provided, however, that subscriptions in lesser amounts
may be accepted by the Company in its sole discretion.

    	 

    	 

    

 

(b)          Placement
of the Securities by the Placement Agents will be made on a reasonable best efforts basis. The Company agrees and acknowledges
that the Placement Agents are not acting as underwriters with respect to the Offering and the Company shall determine the purchasers
in the Offering in its sole discretion The Shares will be offered by the Company to potential subscribers, which may include related
parties of the Placement Agents or the Company, commencing on April 20, 2015 through June 15, 2015 (the “Initial Offering
Period”), which date may be extended by the Company (this additional period and the Initial Offering Period shall be referred
to as the “Offering Period”). The date on which the Offering is terminated shall be referred to as the “Termination
Date”. The closing of the Offering may be held up to ten days after the Termination Date.

 

(c)          The
Company shall only offer securities to and accept subscriptions from or sell Securities to, persons or entities that either (i)
qualify as (or are reasonably believed to be) “accredited investors,” as such term is defined in Rule 501 of Regulation
D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under
Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”).

 

(d)          The
offering of Securities will be made by the Placement Agents on behalf of the Company solely pursuant to the Subscription Agreement
and the Exhibits to the Subscription Agreement, including, but not limited to, and to the extent applicable, the Term Sheet, Registration
Rights Agreement, a draft of the Form 8-K relating to the Merger and the business of Akoustis to be filed by the Company with the
Securities and Exchange Commission (the “Super 8-K”) and the risk factors and disclosures will be available to the
Placement Agents prior to such filing. and any documents, agreements, supplements and additions thereto (collectively, the “Subscription
Documents”), which at all times will be in form and substance reasonably acceptable to the Company and the Placement Agents
and their respective counsel and contain such legends and other information as the Company and the Placement Agents and their respective
counsel, may, from time to time, deem necessary and desirable to be set forth therein.

 

(e)          With
respect to the Offering, the Company shall provide the Placement Agents, on terms set forth herein, the right to offer and sell
all of the available Securities being offered during the Offering Period (subject to prior offer and sale of some of the Securities).
It is understood that no sale shall be regarded as effective unless and until accepted by the Company. The Company may, in their
sole discretion, accept or reject, in whole or in part, any prospective investment in the Securities or allot to any prospective
subscriber less than the number of Securities that such subscriber desires to purchase. Purchases of Securities may be made by
the Placement Agents and their selected sub-dealers and their respective officers, directors, employees and affiliates and by the
officers, directors, employees and affiliates of the Company and Akoustis (collectively, the “Affiliates”) for the
Offering and such purchases will be made by the Affiliates based solely upon the same information that is provided to the investors
in the Offering.

 

2.            Representations,
Warranties and Covenants.

 

A.           Representations,
Warranties and Covenants of the Company. The Company hereby represents and warrants to the Placement Agents that, except as
otherwise set forth in the disclosure schedule provided by the Company to the Placement Agents on the date hereof and as updated,
if necessary, by the Company immediately prior to the closing of the transactions contemplated hereby, and collectively attached
hereto as Exhibit A (the “Company Disclosure Schedule”), and assuming that the conditions described in
Section 6 hereof are satisfied, each of the representations and warranties contained in this Section 2 is true in all respects
as of the date hereof and will be true in all respects as of the Closing Date and any subsequent Closing Dates (which will be deemed
to be following the closing of the Merger), as defined under Section 4(e). In addition to the representations and warranties set
forth herein, the Placement Agents shall be entitled to rely upon the representations and warranties made or given by the Company
to any acquirer of Securities in the Offering in any agreement, certificate, legal opinion or otherwise in connection with an Offering.
For purposes of this Section 2(A), the term Company includes all of the Company’s subsidiaries (if any).

 

    	 

    	 

    

 

(a)          The
Subscription Documents have been and/or will be prepared by the Company, in conformity with all applicable laws, and in compliance
with Regulation D and/or Section 4(a)(2) of the Act and the requirements of all other rules and regulations (the “Regulations”)
of the SEC relating to offerings of the type contemplated by the Offering, and the applicable securities laws and the rules and
regulations of those jurisdictions wherein the Placement Agents notify the Company that the Securities are to be offered and sold
(including U.S. states). The Securities will be offered and sold pursuant to the registration exemption provided by Regulation
D and/or Section 4(a)(2) of the Act as a transaction not involving a public offering and the requirements of any other applicable
state securities laws and the respective rules and regulations thereunder in those United States jurisdictions in which the Placement
Agents notify the Company that the Securities are being offered for sale. None of the Company, its affiliates, or any person acting
on its or their behalf (other than the Placement Agents, their respective affiliates or any person acting on their behalf, in respect
of which no representation is made) has taken nor will it take any action that conflicts with the conditions and requirements of,
or that would make unavailable with respect to the Offering, the exemption(s) from registration available pursuant to Rule 506
of Regulation D and/or Section 4(a)(2) of the Act and applicable state securities laws, or knows of any reason why any such exemption
would be otherwise unavailable to it). Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf,
has directly or indirectly made any offers or sales of any security or solicited any offers to buy any security under circumstances
that would require registration under the Act of the issuance of the Securities or the Brokers Warrants (as hereinafter defined).
None of the Company, its predecessors or affiliates has been subject to any order, judgment or decree of any court of competent
jurisdiction temporarily, preliminarily or permanently enjoining such person for failing to comply with Section 503 of Regulation
D or the equivalent state securities law requirements. The Company has not, for a period of six months prior to the commencement
of the offering of Securities, sold, offered for sale or solicited any offer to buy any of its securities in a manner that would
be integrated with the offer and sale of the Securities pursuant to this Agreement, would cause the exemption from registration
set forth in Rule 506 of Regulation D and state securities laws to become unavailable with respect to the offer and sale of the
Securities to this Agreement in the United States. The Securities, and upon the exercise of the Brokers Warrants pursuant to their
terms, the Brokers Warrant Shares will be quoted on the OTCQB (the “Principal Market”). The Company has taken
no action designed to, or likely to have the effect of, terminating the quotation of the Common Stock (including the Securities
and the Brokers Warrant Shares) on the Principal Market. The Company, on the Closing Date, will be in compliance with all of the
then-applicable requirements for continued quotation of the Common Stock on the Principal Market.

 

(b)          The
Subscription Documents, as prepared and contemplated by the Company, will not and do not include any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading. To the knowledge of the Company, none of the statements, documents,
certificates or other items made, prepared or supplied by the Company with respect to the transactions contemplated hereby contains
an untrue statement of a material fact or omits to state a material fact necessary to make the statements contained therein not
misleading in light of the circumstances in which they were made. There is no fact which the Company has not disclosed in the Subscription
Documents or which is not disclosed in the filings (the “SEC Filings”, which is deemed to include the Super 8-K) that
the Company makes with the US Securities and Exchange Commission (the “SEC”) and of which the Company is aware that
materially adversely affects or that could reasonably be expected to have a material adverse effect on the (i) assets, liabilities,
results of operations, condition (financial or otherwise), business or business prospects of the Company, including the business
prospects as a result of the Merger or (ii) ability of the Company to perform its obligations under this Agreement and the other
Subscription Documents (the “Company Material Adverse Effect”). Notwithstanding anything to the contrary herein, the
Company makes no representation or warranty with respect to any estimates, projections and other forecasts and plans (including
the reasonableness of the assumptions underlying such estimates, projections and other forecasts and plans) that may have been
delivered to the Placement Agents or their respective representatives, except that such estimates, projections and other forecasts
and plans have been prepared in good faith on the basis of assumptions stated therein, which assumptions were believed to be reasonable
at the time of such preparation. Other than the Company’s SEC Filings, the Company has not distributed and will not distribute
prior to the Closing any offering material in connection with the offering and sale of the Securities, unless such offering materials
are provided to the Placement Agents prior to or simultaneously with such delivery to the offerees of the Securities.

 

    	 

    	 

    

 

(c)          The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada and is qualified
and in good standing as a foreign corporation in each jurisdiction in which the nature of the business conducted by the Company
or the property owned or leased by the Company requires such qualification, except to the extent that the failure to be so qualified
or be in good standing would not have a Company Material Adverse Effect. The Company has all requisite corporate power and authority
to conduct its business as presently conducted and as proposed to be conducted (as described in the Subscription Documents and/or
the SEC Filings), has all the necessary and requisite documents and approvals from all state authorities, has all requisite corporate
power and authority to enter into and perform its obligations under this Agreement, the Subscription Agreement substantially in
the form made part of the Subscription Documents (the “Subscription Agreement”), the Registration Rights Agreement
substantially in the form made part of the Subscription Documents (the “Registration Rights Agreement”), and the other
agreements, if any, contemplated by the Offering (this Agreement, Subscription Agreement, the Registration Rights Agreement and
the other agreements contemplated hereby that the Company is required to execute and deliver are collectively referred to herein
as the “Company Transaction Documents”) and subject to necessary Board and stockholder approvals, to issue,
sell and deliver the Common Stock and the shares of Common Stock (the “Brokers Warrant Shares”) issuable upon exercise
of the Brokers Warrants (as defined below) and to make the representations in this Agreement accurate and not misleading. Prior
to the First Closing, as defined under Section 4(e), each of the Company Transaction Documents and the Offering will have been
duly authorized. This Agreement has been duly authorized, executed and delivered and constitutes, and each of the other Company
Transaction Documents, upon due execution and delivery, will constitute, valid and binding obligations of the Company, enforceable
against the Company in accordance with their respective terms (i) except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws now or hereafter in effect related to laws affecting creditors’
rights generally, including the effect of statutory and other laws regarding fraudulent conveyances and preferential transfers,
and except that no representation is made herein regarding the enforceability of the Company’s obligations to provide indemnification
and contribution remedies under the securities laws and (ii) subject to the limitations imposed by general equitable principles
(regardless of whether such enforceability is considered in a proceeding at law or in equity).

 

(d)          None
of the execution and delivery of or performance by the Company under this Agreement or any of the other Company Transaction Documents
or the consummation of the transactions in this Agreement or in the Subscription Documents (including the issuance and sale of
the Securities, the issuance of the Brokers Warrants or the issuance and sale of the Brokers Warrants Shares conflicts with or
violates, or causes a default under (with our without the passage of time or the giving of notice), or will result in the creation
or imposition of, any lien, charge or other encumbrance upon any of the assets of the Company under any agreement, evidence of
indebtedness, joint venture, commitment or other instrument to which the Company is a party or by which the Company or its assets
may be bound, any statute, rule, law or governmental regulation applicable to the Company, or any term of the Article of Incorporation
as in effect on the date hereof or any closing date for the Offering (the “Articles of Incorporation”) or By-Laws as
in effect on the date hereof or any closing date for the Offering (the “By-Laws”) of the Company, or any license, permit,
judgment, decree, order, statute, rule or regulation applicable to the Company or any of its assets, except in the case of a conflict,
violation, lien, charge or other encumbrance (except with respect to the Company’s Articles of Incorporation or By-Laws)
which would not, or could not reasonably be expected to, have a Company Material Adverse Effect. No consent, approval, authorization
or other order of, or registration, qualification or filing with, any regulatory body, administrative agency, or other governmental
body is required for the execution and delivery of this Agreement by the Company and the valid issuance or sale of the Securities,
the Brokers Warrants and the Brokers Warrant Shares by the Company pursuant to this Agreement, other than such as have been made
or obtained and that remain in full force and effect, and except for the filing of a Form D or any filings required to be made
under state securities laws, which shall be timely filed by the Company.

 

    	 

    	 

    

(e)          The
Company’s financial statements, together with the related notes, if any, included in the Subscription Documents or the Company’s
SEC Filings, present fairly, in all material respects, the financial position of the Company as of the dates specified and the
results of operations for the periods covered thereby. Such financial statements and related notes were prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis throughout the periods indicated, except
that the unaudited financial statements omit full notes, and except for normal year end adjustments. If the financials for the
Company are unaudited financial statements, it will state such clearly on the financials. During the period of engagement of the
Company’s independent certified public accountants, there have been no disagreements between the accounting firm and the
Company on any matters of accounting principles or practices, financial statement disclosure or auditing scope or procedures. The
Company has made and kept books and records and accounts which are in reasonable detail and which fairly and accurately reflect
the activities of the Company in all material respects, subject only to year-end adjustments. Except as set forth in such financial
statements or otherwise disclosed in the Subscription Documents, the Company’s senior management has no knowledge of any
material liabilities of any kind, whether accrued, absolute or contingent, or otherwise, and subsequent to the date of the Subscription
Documents and prior to the date of the First Closing, it shall not enter into any material transactions or commitments without
promptly thereafter notifying the Placement Agents and the purchasers in the Offering in writing of any such material transaction
or commitment. The other financial and statistical information with respect to the Company and any pro forma information and related
notes included in the SEC Filings present fairly the information shown therein on a basis consistent with the financial statements
of the Company included in the SEC Filings. Except as disclosed in the Subscription Documents, the Company does not know of any
facts, circumstances or conditions which could materially adversely affect its operations, earnings or prospects that have not
been fully disclosed in the financial statements appearing in the SEC Filings or other financial statements appearing in the SEC
Filings or other documents or information provided by the Company.

 

(f)          Immediately
prior to the First Closing, the shares of Common Stock and the Brokers Warrants Shares will have been duly authorized and, when
issued and delivered against payment therefor as provided in the Company Transaction Documents, will be validly issued, fully paid
and nonassessable. No holder of any of the shares of Common Stock and Brokers Warrants Shares will be subject to personal liability
solely by reason of being such a holder, and except as described in the Subscription Documents, none of the shares of Common Stock,
the Brokers Warrants or the Brokers Warrants Shares will be subject to preemptive or similar rights of any stockholder or security
holder of the Company or an adjustment under the antidilution or exercise rights of any holders of any outstanding shares of capital
stock, options, warrants or other rights to acquire any securities of the Company. Immediately prior to the First Closing, a sufficient
number of authorized but unissued shares of Common Stock will have been reserved for issuance upon the exercise of the Brokers
Warrants.

    	 

    	 

    

 

 

(g)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings and for the Brokers Warrants, and as of the date
of each Closing: (i) there will be no outstanding options, stock subscription agreements, warrants or other rights permitting or
requiring the Company or others to purchase or acquire any shares of capital stock or other equity securities of the Company or
to pay any dividend or make any other distribution in respect thereof; (ii) there will be no securities issued or outstanding which
are convertible into or exchangeable for any of the foregoing and there are no contracts, commitments or understandings, whether
or not in writing, to issue or grant any such option, warrant, right or convertible or exchangeable security; (iii) no Securities
of the Company or other securities of the Company are reserved for issuance for any purpose; (iv) there will be no voting trusts
or other contracts, commitments, understandings, arrangements or restrictions of any kind with respect to the ownership, voting
or transfer of shares of stock or other securities of the Company, including, without limitation, any preemptive rights, rights
of first refusal, proxies or similar rights, and (v) no person prior to the execution of this Agreement by the Company holds a
right to require the Company to register any securities of the Company under the Act or to participate in any such registration.
Immediately prior to the First Closing, the issued and outstanding shares of capital stock of the Company will conform in all material
respects to all statements in relation thereto contained in the Company’s SEC Filings and the Company’s SEC Filings
describe all material terms and conditions thereof. All issuances by the Company of its securities have been issued pursuant to
either a current effective registration statement under the 1933 Act or an exemption from registration requirements under the Act,
and were issued in accordance with any applicable Federal and state securities laws.

 

(h)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings, the Company has no subsidiaries and does not
own any equity interest and has not made any loans or advances to or guarantees of indebtedness to any person, corporation, partnership
or other entity and is not a party to any joint venture. The Company’s subsidiaries are duly incorporated or organized, validly
existing and in good standing under the laws of their jurisdiction of incorporation or organization and have all requisite power
and authority to carry on their business as now conducted. Such subsidiaries are duly qualified to transact business and is in
good standing in each jurisdiction in which the failure to so qualify would have a material adverse effect on their respective
business or properties. All of the outstanding capital stock or other voting securities of such subsidiaries are owned by the Company,
directly or indirectly, free and clear of any liens, claims, or encumbrances. The conduct of business by the Company as presently
and proposed to be conducted is not subject to continuing oversight, supervision, regulation or examination by any governmental
official or body of the United States, or any other jurisdiction wherein the Company conducts or proposes to conduct such business,
except as described in the Subscription Documents and/or the Company’s SEC Filings and except as such regulation is applicable
to US public companies and commercial enterprises generally. The Company has obtained all material licenses, permits and other
governmental authorizations necessary to conduct its business as presently conducted. The Company has not received any notice of
any violation of, or noncompliance with, any federal, state, local or foreign laws, ordinances, regulations and orders (including,
without limitation, those relating to environmental protection, occupational safety and health, securities laws, equal employment
opportunity, consumer protection, credit reporting, “truth-in-lending”, and warranties and trade practices) applicable
to its business, the violation of, or noncompliance with, would have a Company Material Adverse Effect, and the Company knows of
no facts or set of circumstances which could give rise to such a notice.

 

(i)          Except
as described in the Subscription Documents and/or the Company’s SEC Filings, no default by the Company or, to the knowledge
of the Company, any other party, exists in the due performance under any material agreement to which the Company is a party or
to which any of its assets is subject (collectively, the “Company Agreements”). The Company Agreements, if any, disclosed
in the Subscription Documents and/or the Company’s SEC Filings are the only material agreements to which the Company is bound
or by which its assets are subject, are accurately described in the Subscription Documents and/or the Company’s SEC Filings
and are in full force and effect in accordance with their respective terms, subject to any applicable bankruptcy, insolvency or
other laws affecting the rights of creditors generally and to general equitable principles and the availability of specific performance.

 

    	 

    	 

    

 

(j)          Subsequent
to the respective dates as of which information is given in the Subscription Documents, the Company has operated its business in
the ordinary course and, except as may otherwise be set forth in the Subscription Documents or the Company’s SEC Filings,
there has been no: (i) Company Material Adverse Effect; (ii) material transaction otherwise than in the ordinary course of
business consistent with past practice; (iii) issuance of any securities (debt or equity) or any rights to acquire any such
securities other than pursuant to equity incentive plans approved by its Board of Directors; (iv) damage, loss or destruction,
whether or not covered by insurance, with respect to any material asset or property of the Company; or (v) agreement to permit
any of the foregoing.

 

(k)          Except
as set forth in the Subscription Documents and/or the Company’s SEC Filings, there are no actions, suits, claims, hearings
or proceedings pending before any court or governmental authority or, to the knowledge of the Company, threatened, against the
Company, or involving its assets or any of its officers or directors (in their capacity as such) which, (i) if determined adversely
to the Company or such officer or director, could reasonably be expected to have a Company Material Adverse Effect or adversely
affect the transactions contemplated by this Agreement or the Company Transaction Documents (as defined in this Agreement) or the
enforceability hereof or (ii) would be required to be disclosed in the Company’s Annual Report on Form 10-K under the requirements
of Item 103 of Regulation S-K. The Company is not subject to any injunction, judgment, decree or order of any court, regulatory
body, arbitral panel, administrative agency or other government body.

 

(l)          The
Articles of Incorporation and By-laws of the Company are true, correct and complete copies of the certificate of incorporation
and bylaws of the Company, as in effect on the date hereof. Any subsequent amendments to the certificate of incorporation or bylaws
will be provided promptly to the Placement Agents and investors in the Offering. The Company is not: (i) in violation of its Articles
of Incorporation or By-Laws; (ii) in default of any contract, indenture, mortgage, deed of trust, note, loan agreement, security
agreement, lease, alliance agreement, joint venture agreement or other agreement, license, permit, consent, approval or instrument
to which the Company is a party or by which it is or may be bound or to which any of its assets may be subject, the default of
which could reasonably be expected to have a Company Material Adverse Effect; (iii) in violation of any statute, rule or regulation
applicable to the Company, the violation of which would have a Company Material Adverse Effect; or (iv) in violation of any judgment,
decree or order of any court or governmental body having jurisdiction over the Company and specifically naming the Company, which
violation or violations individually, or in the aggregate, could reasonably be expected to have a Company Material Adverse Effect.

 

(m)          Except
as disclosed in the Subscription Documents and/or the Company’s SEC Filings, as of the date of this Agreement, no current
or former stockholder, director, officer or employee of the Company, nor, to the knowledge of the Company, any affiliate of any
such person is presently, directly or indirectly through his/her affiliation with any other person or entity, a party to any loan
from the Company or any other transaction (other than as an employee) with the Company.

 

(n)          The
Company is not obligated to pay, and has not obligated the Placement Agents to pay, a finder’s or origination fee in connection
with the Offering other than to the Placement Agents under this Agreement, and hereby agrees to indemnify the Placement Agents
from any such claim made by any other person as more fully set forth in Section 8 hereof. The Company has not offered for sale
or solicited offers to purchase the Securities except for negotiations with the designated Placement Agents. Except as set forth
in the Subscription Documents, no other person has any right to participate in any offer, sale or distribution of the Company’s
securities to which the Placement Agents’ rights, described herein, shall apply.

 

(o)          Until
the earlier of (i) the Termination Date or (ii) the Final Closing (as hereinafter defined), the Company will not issue any press
release, grant any interview, or otherwise communicate with the media in any manner whatsoever with respect to the Offering without
the Placement Agents’ prior written consent, which consent will not unreasonably be withheld or delayed, and subject to any
applicable laws and regulations.

 

    	 

    	 

    

 

(p)          No
representation or warranty contained in Section 2A of this Agreement contains any untrue statement of a material fact or omits
to state a material fact necessary to make the statements herein not misleading in the context of such representations and warranties.
The Placement Agents shall be entitled to rely on such representations and warranties.

 

(q)          No
consent, authorization or filing of or with any court or governmental authority is required in connection with the issuance or
the consummation of the transactions contemplated herein or in the other Company Transaction Documents, except for required filings
with the SEC and the applicable state securities commissions relating specifically to the Offering (all of which filings will be
duly made by, or on behalf of, the Company), and those which are required to be made after the First Closing (all of which will
be duly made on a timely basis).

 

(r)          Neither
the sale of the Securities by the Company nor its use of the proceeds thereof will violate the Trading with the Enemy Act, as amended,
nor any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended)
or any enabling legislation or executive order relating thereto. Without limiting the foregoing, the Company is not (a) a person
whose property or interests in property are blocked pursuant to Section 1 of Executive Order 13224 of September 23, 2001 Blocking
Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism (66 Fed. Reg. 49079 (2001))
or (b) a person who engages in any dealings or transactions, or be otherwise associated, with any such person. The Company and
its subsidiaries, if any, are in compliance, in all material respects, with the USA Patriot Act of 2001 (signed into law October
26, 2001). Each of the Company, its affiliates and any of their respective officers, directors, supervisors, managers, agents,
or employees, has not violated, its participation in the offering will not violate, and the Company has instituted and maintains
policies and procedures designed to ensure continued compliance with, each of the following laws:  (a) anti-bribery laws,
including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any law, rule,
or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business
Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any other
law, rule or regulation of similar purposes and scope, (b) anti-money laundering laws, including but not limited to, applicable
federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including,
without limitation, Title 18 US. Code section 1956 and 1957, the Bank Secrecy Act, and international anti-money laundering principles
or procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which
the United States is a member and with which designation the United States representative to the group or organization continues
to concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the  foregoing,
or any orders or licenses issued thereunder or (c) laws and regulations imposing U.S. economic sanctions measures, including, but
not limited to, the International Emergency Economic Powers Act, the United Nations Participation Act and the Syria Accountability
and Lebanese Sovereignty Act, all as amended, and any Executive Order, directive, or regulation pursuant to the authority of any
of the foregoing, including the regulations of the United States Treasury Department set forth under 31 CFR, Subtitle B, Chapter
V, as amended, or any orders or licenses issued thereunder.  Neither the Company nor any director, officer, agent, employee
or other person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; or
(iii) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic
government official or employee.

 

    	 

    	 

    

 

(s)          None
of Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the Offering, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated on
the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered Persons”)
is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)–(viii) under the Securities
Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) or has been
involved in any matter which would be a Disqualification Event except for the fact that it occurred before September 23, 2013.
The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Placement Agent a copy of any disclosures provided thereunder.

 

(t)          The
Company is not aware of any person (other than any Issuer Covered Person or Placement Agent Covered Person (as defined below) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
the Securities. For purposes of this subsection Placement Agent Covered Person shall mean Northland Securities, Inc. and Katalyst
Securities Inc., or any of its directors, executive officers, general partners, managing members or other officers participating
in the Offering.

 

(u)          The
Company will promptly notify the Placement Agent in writing of (A) any Disqualification Event relating to any Issuer Covered Person
and (B) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.
The Company will notify the Agent in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer
Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer
Covered Person.

 

(v)         The
authorized capital stock of the Company as of the First Closing will be set forth in the Company’s SEC Filings. As of the
First Closing, the Company’s issued and outstanding capital stock will be set forth in the Company’s SEC Filings. All
issued and outstanding shares of capital stock have been duly authorized and validly issued, are fully paid and nonassessable,
were not issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities, and, except as
disclosed in the Company’s SEC Filings, have been issued and sold in compliance with the registration requirements of federal
and state securities laws or the applicable statutes of limitation have expired. Except as set forth in the Company’s SEC
Filings, there are no (i) outstanding rights (including, without limitation, preemptive rights), warrants or options to acquire,
or instruments convertible into or exchangeable for, any unissued shares of capital stock or other equity interest in the Company,
or any contract, commitment, agreement, understanding or arrangement of any kind to which the Company or its subsidiaries is a
party and relating to the issuance or sale of any capital stock or convertible or exchangeable security of the Company; or (ii)
obligations of the Company to purchase redeem or otherwise acquire any of its outstanding capital stock or any interest therein
or to pay any dividend or make any other distribution in respect thereof.

 

    	 

    	 

    

 

(w)          The
Company has ownership or license or legal right to use all patents, copyrights, trade secrets, know-how, trademarks, trade names,
customer lists, designs, manufacturing or other processes, computer software, systems, data compilation, research results or other
proprietary rights used in the business of the Company or its subsidiaries (collectively “Intellectual Property”).
All of such patents, registered trademarks and registered copyrights have been duly registered in, filed in or issued by the United
States Patent and Trademark Office, the United States Register of Copyrights or the corresponding offices of other jurisdictions
and have been maintained and renewed in accordance with all applicable provisions of law and administrative regulations in the
United States and all such jurisdictions. The Company believes it has taken all reasonable steps required in accordance with sound
business practice and business judgment to establish and preserve its and its subsidiaries’ ownership of all material Intellectual
Property with respect to their products and technology. To the knowledge of the Company, there is no infringement of the Intellectual
Property by any third party. To the knowledge of the Company, the present business, activities and products of the Company and
its subsidiaries do not infringe any intellectual property of any other person. There is no proceeding charging the Company or
its subsidiaries with infringement of any adversely held Intellectual Property has been filed and the Company is unaware of any
facts which are reasonably likely to form a basis for any such proceeding. There are no proceedings have been instituted or pending
or, to the knowledge of the Company, threatened, which challenge the rights of the Company or its subsidiaries to the use of the
Intellectual Property. The Intellectual Property owned by the Company and its subsidiaries, and to the knowledge of the Company,
the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged invalid or unenforceable, in whole
or in part. There is no pending or, to the knowledge of the Company, threatened proceeding by others challenging the validity or
scope of any such Intellectual Property, and the Company is unaware of any facts which are reasonably likely to form a basis for
any such claim. Each of the Company and its subsidiaries has the right to use, free and clear of material claims or rights of other
persons, all of its customer lists, designs, computer software, systems, data compilations, and other information that are required
for its products or its business as presently conducted. Neither the Company nor its subsidiaries is making unauthorized use of
any confidential information or trade secrets of any person. The activities of any of the employees on behalf of the Company or
of its subsidiaries do not violate any agreements or arrangements between such employees and third parties are related to confidential
information or trade secrets of third parties or that restrict any such employee’s engagement in business activity of any
nature. Each former and current employee or consultant of the Company or its subsidiaries is a party to a written contract with
the Company or its subsidiaries that assigns to the Company or its subsidiaries, or has received an employee handbook that requires
an employee to assign, all rights to all inventions, improvements, discoveries and information relating to the Company or its subsidiaries,
except for any failure to so do as would not reasonably be expected to result in a Material Adverse Effect. All licenses or other
agreements under which (i) the Company or its subsidiaries employs rights in Intellectual Property, or (ii) the Company or its
subsidiaries has granted rights to others in Intellectual Property owned or licensed by the Company or its subsidiaries are in
full force and effect, and there is no default (and there exists no condition which, with the passage of time or otherwise, would
constitute a default by the Company or such subsidiary) by the Company or its subsidiaries with respect thereto.

 

(x)          Marcum
LLP and KLJ & Associates, LLP, who will express their opinion with respect to the consolidated financial statements contained
in the Company SEC Documents, have advised the Company that they are, and to the knowledge of the Company they are, independent
accountants as required by the Securities Act and the rules and regulations promulgated thereunder.

 

(y)          The
Company has filed all necessary federal, state, local and foreign income and franchise tax returns and have paid or accrued all
taxes shown as due thereon, and the Company has no knowledge of a tax deficiency which has been or might be asserted or threatened
against it by any taxing jurisdiction, other than any deficiency which the Company is contesting in good faith and with respect
to which adequate reserves for payment have been established.

 

(z)          The
Company maintains and will continue to maintain insurance of the types and in the amounts that the Company reasonably believes
are adequate for its business, including, but not limited to, insurance covering all real and personal property owned or leased
by the Company against theft, damage, destruction, acts of vandalism and all other risks customarily insured against by similarly
situated companies, all of which insurance is in full force and effect.

 

(aa) On each Closing
Date, all stock transfer or other taxes (other than income taxes) that are required to be paid in connection with the sale and
transfer of the Securities and the Brokers Warrants will be, or will have been, fully paid or provided for by the Company and the
Company will have complied with all laws imposing such taxes.

 

    	 

    	 

    

 

(bb)         The
Company (including its subsidiaries) is not an “investment company” or an “affiliated person” of, or “promoter”
or “principal underwriter” for an investment company, within the meaning of the Investment Company Act of 1940 and
will not be deemed an “investment company” as a result of the transactions contemplated by the Offering.

 

(cc)         The
books, records and accounts of the Company accurately and fairly reflect, in reasonable detail, the transactions in, and dispositions
of, the assets of, and the operations of, the Company.

 

(dd)         The
Company and its subsidiaries have established and maintain disclosure controls and procedures (as such term is defined in Rule
13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”), which (i) are designed to ensure that material
information relating to the Company or its subsidiaries is made known to the Company’s principal executive officer and its
principal financial officer by others within those entities particularly during the periods in which the periodic reports required
under the Securities Exchange Act are being prepared; and (ii) provide for the periodic evaluation of the effectiveness of such
disclosure controls and procedures as of the end of the period covered by the Company’s most recent annual or quarterly report
filed with the SEC. The Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance
with management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared
with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference.
The Company and its subsidiaries maintain disclosure controls and procedures (as such term is defined in Rule 13a-15 under the
Exchange Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files
with or submits to the SEC is recorded, processed, summarized and reported, within the time periods specified in the rules and
forms of the SEC, including, without limitation, controls and procedures designed in to ensure that information required to be
disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the
Company’s management, including its principal executive officer or officers and its principal financial officer or officers,
as appropriate, to allow timely decisions regarding required disclosure. The Company is not aware of (i) any significant deficiency
or material weakness in the design or operation of internal controls which could adversely affect the Company’s or its subsidiaries’
ability to record, process, summarize and report financial data or any material weaknesses in internal controls; or (ii) any fraud,
whether or not material, that involves management or other employees who have a significant role in the Company’s or its
subsidiaries’ internal controls. Since January 1, 2015, there have been no changes that have materially affected, or are
reasonably likely to materially affect, the Company’s or its subsidiaries’ internal control over financial reporting,
including any corrective actions with regard to significant deficiencies and material weaknesses. There are no material off-balance
sheet arrangements (as defined in Item 303 of Regulation S-K), or any other relationships with unconsolidated entities (in which
the Company or its control persons have an equity interest) that may have a material current or future effect on the Company’s
or its subsidiaries’ financial condition, revenues or expenses, changes in financial condition, results of operations, liquidity,
capital expenditures or capital resources. The board of directors has not been informed, nor is any director of the Company aware,
of (1) any significant deficiencies in the design or operation of the internal controls of the Company or its subsidiaries which
could adversely affect the Company’s or its subsidiaries’ ability to record, process, summarize and report financial
data or any material weakness in the Company’s or its subsidiaries’ internal controls; or (2) any fraud, whether or
not material, that involves management or other employees of the Company or its subsidiaries who have a significant role in the
Company’s or its subsidiaries’ internal controls.

 

    	 

    	 

    

 

(ee)         Neither
the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or will engage in any form of
general solicitation or general advertising (within the meaning of Regulation D promulgated under the Securities Act) in connection
with the offer or sale of the Securities or the Brokers Warrants.

 

(ff)         The
Company is in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that
are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the SEC thereunder that are
effective as of the date hereof.

 

(gg)         The
Company is not a party to any collective bargaining agreement or employs any member of a union. The Company believes that its relations
with its employees are good. No executive officer of the Company (as defined in Rule 501(f) of Regulation D under the Securities
Act) has notified the Company that such officer intends to leave the Company or otherwise terminate such officer’s employment
with the Company. No executive officer of the Company, to the knowledge of the Company, is, or is now expected to be, in violation
of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement, non-competition
agreement, or any other contract or agreement or any restrictive covenant, and the continued employment of each such executive
officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company and its subsidiaries
are in compliance with all federal, state, local and foreign laws and regulations respecting labor, employment and employment practices
and benefits, terms and conditions of employment and wages and hours, except where failure to be in compliance would not, either
individually or in the aggregate, reasonably be expected to result in a Company Material Adverse Effect.

 

(hh)         None
of the Company, its subsidiaries or any executive officer of the Company (as defined in Rule 501(f) of Regulation D under the Securities
Act) has taken and will not take any action designed to or that might reasonably be expected to cause or result in an unlawful
manipulation of the price of the Common Stock to facilitate the sale or resale of the Securities, the Brokers Warrants or the Brokers
Warrant Shares. The Company confirms that, to its knowledge, with the exception of the proposed sale of Securities, neither it
nor any other person acting on its behalf has provided any of the potential investors or their agent or counsel with any information
that constitutes or might constitute material, non-public information. The Company understands and confirms that the potential
investors shall be relying on the foregoing representations in effecting transactions in securities of the Company.

 

(ii)         The
Company and its board of directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition,
business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision
under the Company’s certificate of incorporation or the laws of the jurisdiction of its formation which is or could become
applicable to any potential investor as a result of the transactions contemplated by the Offering, including, without limitation,
the Company’s issuance of the Securities and any potential investor’s ownership of the Securities. The Company has
not adopted a stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership of its capital stock
or a change in control of the Company.

 

(jj)         The
Company acknowledges that the Placement Agents, their sub agents, legal counsel to the Company and/or their respective affiliates,
principals, representatives or employees may now or hereafter own shares of the Company.

 

B.           Representations,
Warranties and Covenants of Northland. Northland hereby represents and warrants to the Company that the following representations
and warranties are true and correct as of the date of this Agreement:

    	 

    	 

    

 

(a)          Northland
represents that neither it, nor to its knowledge any of its Sub- Agents or any of its or their respective directors, executive
officers, general partners, managing members or other officers participating in the Offering (each, a “Northland Covered
Person” and, together, “Northland Covered Persons”), is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”) or has been involved
in any matter which would be a Disqualification Event except for the fact that it occurred before September 23, 2013.

 

(b)          Northland
will notify the Company promptly in writing of any Disqualification Event relating to any Northland Covered Person not previously
disclosed to the Company in accordance with the prior section.

 

C.           Representations,
Warranties and Covenants of Katalyst. Katalyst hereby represents and warrants to the Company that the following representations
and warranties are true and correct as of the date of this Agreement:

 

(a)          Katalyst
represents that neither it, nor to its knowledge any of its Sub- Agents or any of its or their respective directors, executive
officers, general partners, managing members or other officers participating in the Offering (each, a “Katalyst Covered Person”
and, together, “Katalyst Covered Persons”), is subject to any of the “Bad Actor” disqualifications described
in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”) or has been involved in
any matter which would be a Disqualification Event except for the fact that it occurred before September 23, 2013.

 

(b)          Katalyst
will notify the Company promptly in writing of any Disqualification Event relating to any Katalyst Covered Person not previously
disclosed to the Company in accordance with the prior section.

 

3.           Placement
Agents Compensation.

 

(a)          In
connection with the Offering, the Company will pay a cash fee (the “Broker Cash Fee”) to the Placement Agents at each
Closing equal to 10% of each Closing’s gross proceeds from any sale of Securities in the Offering during the Term; except
for proceeds raised from certain existing investors of Akoustis for which the Placement Agents shall be entitled to a cash fee
equal to 2% of such proceeds. The Broker Cash Fee shall be paid to the Placement Agents in cash by wire transfer from the escrow
account established for the Offering, and as a condition to closing, simultaneous with the distribution of funds to the Company.
The allocation of the Broker Cash Fee between the Placement Agents (and their designees, if applicable) shall be provided in writing
by the Placement Agents.

 

(b)          Also,
at each Closing, the Company will sell for an aggregate price of $10.00 to the Placement Agents (or their designees), warrants
in the form of Attachment I to purchase shares of the Company’s Common Stock equal, in the aggregate, to 10% of the
number of Securities sold in the Offering, which warrants shall have an initial exercise price equal to the price per share of
the Securities (“Brokers Warrants”); except for Securities sold to certain existing investors of Akoustis for which
the Placement Agents shall be entitled to warrants to purchase shares of the Company’s Common Stock equal to 2% of such Securities
sold. To the extent permitted by applicable laws, all warrants shall permit unencumbered transfer to the respective Placement Agents’
employees and affiliates and the warrants may be issued directly to the respective Placement Agents’ employees and affiliates
at the respective Placement Agents’ request. The allocation of the Brokers Warrants between the Placement Agents (and their
designees, if applicable) shall be provided in writing by the Placement Agents. The Broker Cash Fee and the Broker Warrants are
sometimes referred to collectively as the “Brokers Fees”).

 

(c)          To
the extent there is more than one Closing, payment of the proportional amount of the Broker Cash Fees will be made out of the gross
proceeds from any sale of Securities sold at each Closing and the Company will issue to the Placement Agents the corresponding
number of Brokers Warrants. All cash compensation and warrants under this Agreement shall be paid directly by the Company to and
in the name provided to the Company by the Placement Agents.

 

    	 

    	 

    

 

(d) Provided
that an Offering is consummated during the Offering Period, the Placement Agents shall be entitled to the Broker Cash Fee and Brokers
Warrants, calculated in the manner provided in Paragraph C with respect to any subsequent public or private offering or other financing
or capital-raising transaction of any kind (“Subsequent Financing”) to the extent that such financing or capital is
provided the Company, or to any Affiliate of the Company, by investors whom the Placement Agents had “introduced” (as
defined below), directly or indirectly, to the Company during the Offering Period if such Subsequent Financing is consummated at
any time within the six-month period following the earlier of expiration or termination of this Agreement or the closing of the
Offering, if an Offering is consummated (the “Tail Period”).  A party “introduced” by the Placement
Agents shall mean an investor who either (i) met with the Company and/or had a conversation with the Company either in person or
via telephone regarding the Offering or (ii) was provided by the Placement Agents with a copy of the Company’s offering memorandum
(or other materials prepared and/or approved by the Company in connection with the Offering) based upon such investor expressing
an interest, directly or indirectly,  to the Placement Agents in investing in the Offering; and in each instance as listed
on an Exhibit that the Placement Agents shall provide in writing to the Company at the closing of the Offering. An “Affiliate”
of an entity shall mean any individual or entity controlling, controlled by or under common control with such entity and any officer,
director, employee, stockholder, partner, member or agent of such entity.

 

4.           Subscription
and Closing Procedures.

 

(a)          The
Company shall cause to be delivered to the Placement Agents copies of the Subscription Documents and has consented, and hereby
consents, to the use of such copies for the purposes permitted by the Act and applicable securities laws and in accordance with
the terms and conditions of this Agreement, and hereby authorizes the Placement Agents and their agents and employees to use the
Subscription Documents in connection with the sale of the Securities until the earlier of (i) the Termination Date or (ii) the
Final Closing, and no person or entity is or will be authorized to give any information or make any representations other than
those contained in the Subscription Documents or to use any offering materials other than those contained in the Subscription Documents
in connection with the sale of the Securities, unless the Company first provides the Placement Agents with notification of such
information, representations or offering materials.

 

(b)          The
Company shall make available to the Placement Agents and their representatives such information, including, but not limited to,
financial information, and other information regarding the Company (the “Information”), as may be reasonably requested
in making a reasonable investigation of the Company and its affairs. The Company shall provide access to the officers, directors,
employees, independent accountants, legal counsel and other advisors and consultants of the Company as shall be reasonably requested
by the Placement Agents. The Company recognizes and agrees that the Placement Agents (i) will use and rely primarily on the Information
and generally available information from recognized public sources in performing the services contemplated by this Agreement without
independently verifying the Information or such other information, (ii) does not assume responsibility for the accuracy of the
Information or such other information, and (iii) will not make an appraisal of any assets or liabilities owned or controlled by
the Company or its market competitors.

 

(c)          Each
prospective purchaser will be required to complete and execute the Subscription Documents, Anti-Money Laundering Form, Accredited
Investor Certification and other documents which will be forwarded or delivered to the Placement Agent at the Placement Agent’s
offices at the address set forth in Section 12 hereof or to an address identified in the Subscription Documents.

    	 

    	 

    

 

(d)          Simultaneously
with the delivery to the Placement Agents of the Subscription Documents, the subscriber’s check or other good funds will
be forwarded directly by the subscriber to the escrow agent and deposited into a non interest bearing escrow account (the “Escrow
Account”) established for such purpose (the “Escrow Agent”). All such funds for subscriptions will be held in
the Escrow Account pursuant to the terms of an escrow agreement among the Company, the Placement Agents and the Escrow Agent.
The Company will pay all fees related to the establishment and maintenance of the Escrow Account. Subject to the receipt of
subscriptions for the amount for Closing, the Company will either accept or reject, for any or no reason, the Subscription Documents
in a timely fashion and at each Closing will countersign the Subscription Documents and provide duplicate copies of such documents
to the Placement Agents for distribution to the subscribers. The Company will give notice to the Placement Agents of its acceptance
of each subscription. The Company, or the Placement Agents on the Company’s behalf, will promptly return to subscribers incomplete,
improperly completed, improperly executed and rejected subscriptions and give written notice thereof to the Placement Agents upon
such return.

 

(e)          If
subscriptions for at least the Minimum Offering Amount for Closing have been accepted prior to the Termination Date, the funds
therefor have been collected by the Escrow Agent and all of the conditions set forth elsewhere in this Agreement are fulfilled,
a closing shall be held promptly with respect to the Securities sold (the “First Closing”). Thereafter, the remaining
Securities will continue to be offered and sold until the earlier of the Termination Date or the date that additional subscription
amounts up to the Maximum Offering amount have been collected by the Escrow Agent. Additional Closings (each a “Closing”,
collectively “Closings”) may from time to time be conducted at times mutually agreed to among the Company and the Placement
Agents with respect to additional Securities sold, with the final closing (“Final Closing”) to occur within 10 days
after the earlier of the Termination Date and the date on which the Maximum Amount has been subscribed for. Delivery of payment
for the accepted subscriptions for the Securities from the funds held in the Escrow Account will be made at each Closing at the
Placement Agents’ offices against delivery of the Securities by the Company at the address set forth in Section 12 hereof
(or at such other place as may be mutually agreed upon between the Company and the Placement Agents), net of amounts agreed upon
by the parties herein, including, the Blue Sky counsel as of such Closing. Executed certificates for the shares of Common Stock
and the Brokers Warrants will be in such authorized denominations and registered in such names as the Placement Agents may request
on or before the date of each Closing (“Closing Date”). The certificates will be forwarded to the subscriber directly
by the stock transfer agent as soon as practicable following each Closing. At each Closing, the Company will (i) deliver irrevocable
issuance instruction to its stock transfer agent for the issuance of certificates representing the shares of Common Stock being
sold, and (ii) issue and deliver the applicable Brokers Warrants.

 

(f)          If
Subscription Documents for the Minimum Offering Amount for Closing have not been received and accepted by the Company on or before
the Termination Date for any reason, the Offering will be terminated, no Securities will be sold, and the Escrow Agent will, at
the request of the Placement Agents, cause all monies received from subscribers for the Securities to be promptly returned to such
subscribers without interest, penalty, expense or deduction.

 

5.            Further
Covenants. The Company hereby covenants and agrees that:

 

(a)          Except
upon prior written notice to the Placement Agents, the Company shall not, at any time prior to the Final Closing, knowingly take
any action which would cause any of the representations and warranties made by it in this Agreement not to be complete and correct
in all material respects on and as of the date of each Closing with the same force and effect as if such representations and warranties
had been made on and as of each such date (except to the extent any representation or warranty relates to an earlier date).

 

    	 

    	 

    

 

(b)          If,
at any time prior to the Final Closing, any event shall occur that causes a Company Material Adverse Effect which as a result it
becomes necessary to amend or supplement the Subscription Documents so that the representations and warranties herein remain true
and correct in all material respects, or in case it shall be necessary to amend or supplement the Subscription Documents to comply
with Regulation D or any other applicable securities laws or regulations, the Company will promptly notify the Placement Agents
and shall, at its sole cost, prepare and furnish to the Placement Agents copies of appropriate amendments and/or supplements in
such quantities as the Placement Agents may reasonably request. The Company will not at any time before the Final Closing prepare
or use any amendment or supplement to the Subscription Documents of which the Placement Agents will not previously have been advised
and furnished with a copy, or which is not in compliance in all material respects with the Act and other applicable securities
laws. As soon as the Company is advised thereof, the Company will advise the Placement Agents and its counsel, and confirm the
advice in writing, of any order preventing or suspending the use of the Subscription Documents, or the suspension of any exemption
for such qualification or registration thereof for offering in any jurisdiction, or of the institution or threatened institution
of any proceedings for any of such purposes, and the Company will use their best efforts to prevent the issuance of any such order
and, if issued, to obtain as soon as reasonably possible the lifting thereof.

 

(c)          The
Company shall comply with the Act, the Exchange Act, the rules and regulations thereunder, all applicable state securities laws
and the rules and regulations thereunder in the states in which the Company’s Blue Sky counsel has advised the Placement
Agents and/or the Company that the Securities are qualified or registered for sale or exempt from such qualification or registration,
so as to permit the continuance of the sales of the Securities, and will file or cause to be filed with the SEC, and shall promptly
thereafter forward or cause to be forwarded to the Placement Agents, any and all reports on Form D as are required. The Company
will pay the attorney’s fee and out of pocket expenses related to the filings for registrations of sale or exemption from
such qualifications with any state securities commissions and any other regulatory agencies. Such fees will be paid at the time
of invoicing, or at the time of Closing, if known, and if not yet invoiced, funds will remain in escrow to cover the estimated
invoice. The Company will pay the invoice or authorize release of the funds from escrow within five (5) days of receipt of invoice.

 

(d)          The
Company, at its own cost and expense, shall use best efforts to qualify the Securities for sale under the securities laws of such
jurisdictions in the United States as may be mutually agreed to by the Company and the Placement Agents, and the Company will make
or cause to be made such applications and furnish information as may be required for such purposes, provided that the Company will
not be required to qualify as a foreign corporation in any jurisdiction or execute a general consent to service of process. The
Company will, from time to time, prepare and file such statements and reports as are or may be required to continue such qualifications
in effect for so long a period as the Placement Agents may reasonably request with respect to the Offering.

 

(e)          The
Company shall place a legend on the certificates representing the shares of the Common Stock and the Brokers Warrants that the
securities evidenced thereby have not been registered under the Act or applicable state securities laws, setting forth or referring
to the applicable restrictions on transferability and sale of such securities under the Act and applicable state laws.

 

(f)          The
Company shall apply the net proceeds from the sale of the Securities for the purposes set forth in the Subscription Documents.
Except as set forth in the Subscription Documents, the Company shall not use any of the net proceeds of the Offering to repay indebtedness
to officers (other than accrued salaries incurred in the ordinary course of business), directors or stockholders of the Company
without the prior written consent of the Placement Agents.

 

(g)          During
the Offering Period, the Company shall afford each prospective purchaser of Securities the opportunity to ask questions of and
receive answers from an officer of the Company concerning the terms and conditions of the Offering and the opportunity to obtain
such other additional information necessary to verify the accuracy of the Subscription Documents to the extent the Company possesses
such information or can acquire it without unreasonable expense.

    	 

    	 

    

 

(h)          Except
with the prior written consent of the Placement Agents, the Company shall not, at any time prior to the earlier of the Final Closing
or the Termination Date, except as contemplated by the Subscription Documents (i) engage in or commit to engage in any transaction
other than the Merger outside the ordinary course of business as described in the Subscription Documents, (ii) issue, agree to
issue or set aside for issuance any securities (debt or equity) or any rights to acquire any such securities, (iii) incur, outside
the ordinary course of business, any material indebtedness, (iv) dispose of any material assets, (v) make any material acquisition
or (vi) change its business or operations in any material respect.

 

(i)          Whether
or not the transactions contemplated hereby are consummated, or this Agreement is terminated, the Company shall pay all reasonable
expenses incurred in connection with the preparation and printing of all necessary offering documents and instruments related to
the Offering and the issuance of the Common Stock and the Brokers Warrants and will also pay for the Company’s expenses for
accounting fees, legal fees, printing costs, and other costs involved with the Offering. The Company will provide at its own expense
such quantities of the Subscription Documents and other documents and instruments relating to the Offering as the Placement Agents
may reasonably request. The Company will pay at its own expense in connection with the creation, authorization, issuance, transfer
and delivery of the Securities, including, without limitation, fees and expenses of any transfer agent or registrar; the fees and
expenses of the Escrow Agent; all fees and expenses of legal, accounting and other advisers to the Company; the registration or
qualification of the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions, payable within
five (5) days of being invoiced. The Company will pay all such amounts, unless previously paid, at the First Closing, or, if there
is no Closing, within ten (10) days after written request therefor following the Termination Date. In addition to any fees payable
to the Placement Agents hereunder and regardless of whether a Merger or Offering is consummated, the Company hereby agrees to promptly
reimburse the Placement Agents upon written request as follows: Northland’s legal counsel fees in the amount of Fifty Thousand
Dollars ($50,000) and Northland’s reasonable out-of-pocket expenses not to exceed Ten Thousand Dollars ($10,000) and Katalyst’s
legal counsel fees in the amount of Twenty Five Thousand Dollars ($25,000) and Katalyst’s reasonable out-of-pocket expenses
not to exceed Five Thousand Dollars ($5,000). Out-of-pocket expenses, include, but are not limited to, the fees and disbursements
related to travel, database, FedEx, messenger, investor presentations, WebEx presentations, printing and other reasonable out-of-pocket
expenses incurred in performing the services described herein. This reimbursement obligation is in addition to the reimbursement
of fees and expenses relating to attendance by the Placement Agents at proceedings or to indemnification and contribution as contemplated
elsewhere in this agreement. In the event either Placement Agent’s personnel must attend or participate in judicial or other
proceedings to which we are not a party relating to the subject matter of this agreement, the Company shall pay such Placement
Agents an additional per diem payment, per person, at our customary rates, together with reimbursement of all out-of-pocket expenses
and disbursements, including reasonable attorneys’ fees and disbursements incurred by it in respect of its preparation for
and participation in such proceedings. The Placement Agents’ legal counsel fees do not include the Registration Legal Fees
and expenses for the Blue Sky and other regulatory filings to be made in connection with the Offering(s).

 

(j)          On
each Closing Date, the Company permits the Placement Agents to rely on any representations and warranties made by the Company to
the investors and will cause its counsel to permit the Placement Agents to rely upon any opinion furnished to the investors in
the Private Placement.

 

(k)          The
Company will comply with all of its obligations and covenants set forth in its agreements with the investors in the Offering. If
not filed on EDGAR, the Company will promptly deliver to the Placement Agent and their counsel copies of any and all filings with
the SEC and each amendment or supplement thereto, as well as all prospectuses and free writing prospectuses, prior to the closing
of the Offering and six months thereafter. The Placement Agents are authorized on behalf of the Company to use and distribute copies
of any Subscription Documents, including Company’s SEC Filings in connection with the sale of the Securities as, and to the
extent, permitted by federal and applicable state securities laws. The Company acknowledges and agrees that the Placement Agents
will be relying, without assuming responsibility for independent verification, on the accuracy and completeness of all financial
and other information that is and will be furnished to them by the Company and the Company will be liable for any material misstatements
or omissions contained therein.

 

    	 

    	 

    

 

6.           Conditions
of Placement Agents’ Obligations. The obligations of the Placement Agents hereunder to affect a Closing are subject
to the fulfillment, at or before each Closing, of the following additional conditions:

 

(a)          Each
of the representations and warranties made by the Company (which shall take into account that the Merger has been consummated such
that all representations and warranties referring to the Company shall relate to the Company and its subsidiaries following completion
of the Merger) shall be true and correct on each Closing Date.

 

(b)          The
Company shall have performed and complied in all material respects with all agreements, covenants and conditions required to be
performed, and complied with by it at or before the Closing.

 

(c)          The
Subscription Documents do not, and as of the date of any amendment or supplement thereto will not, include any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading.

 

(d)          No
order suspending the use of the Subscription Documents or enjoining the Offering or sale of the Securities shall have been issued,
and no proceedings for that purpose or a similar purpose shall have been initiated or pending, or, to the best of the Company’s
knowledge, be contemplated or threatened.

 

(e)          No
holder of any of the Securities from the Offering will be subject to personal liability solely by reason of being such a holder,
and except as described in the Subscription Documents, none of the Company’s shares of Common Stock and Brokers Warrant Shares
will be subject to preemptive or similar rights of any stockholder or security holder of the Company, or an adjustment under the
antidilution or exercise rights of any holders of any outstanding shares of capital stock, membership units, options, warrants
or other rights to acquire any securities of the Company. 

 

(f)          There
shall have been no material adverse change nor development involving a prospective change in the financial condition, operations
or projects of the Company, except where such change would not have a Company Material Adverse Effect on the business activities,
financial or otherwise, results of operations or prospects of the Company, taken individually or in the aggregate.

 

(g)          The
Placement Agents shall have received a certificate of the Chief Executive Officer of the Company, dated as of the Closing Date,
certifying, as to the fulfillment of the conditions set forth in subparagraphs (a), (b), (c), (d), (e) and (f) above.

 

(h)          The
Company shall have delivered to the Placement Agents: (i) a good standing certificate dated as of a date within 10 days prior to
the date of the First Closing from the secretary of state of its jurisdiction of incorporation and (ii) resolutions of the Company’s
Board of Directors approving this Agreement and the transactions and agreements contemplated by this Agreement, and the Subscription
Documents, all as certified by the Chief Executive Officer of the Company.

 

(i)          At
each Closing, the Company shall have (i) paid to the Placement Agents the Broker Cash Fee in respect of all Securities sold
at such Closing, (ii) executed and delivered to the Placement Agents the Brokers Warrants in respect of all Securities sold
at such Closing, and (iii) paid all fees, costs and expenses as set forth in Section 5 hereof.

 

(j)          There
shall have been delivered to the Placement Agents a signed opinion of counsel to the Company dated as of the Closing Date, in the
form set forth in Attachment II.

 

    	 

    	 

    

 

(k)          Prior
to the closing of the Offering, the Company shall have engaged Continental Stock Transfer & Trust Company as its transfer agent
for purposes of handling the transfers of its capital stock and other securities

 

(l)          All
proceedings taken at or prior to the Closing in connection with the authorization, issuance and sale of the Common Stock and the
Brokers Warrants will be reasonably satisfactory in form and substance to the Placement Agents and their counsel, and such counsel
shall have been furnished with all such documents, certificates and opinions as it may reasonably request upon reasonable prior
notice in connection with the transactions contemplated hereby.

 

(m)          If
in connection with the Offering, the Placement Agents determine that they or the Company would be required to make a filing with
the FINRA to enable the Placement Agents to act as agents in the Offering, the Company will do the following: The Company will
cooperate with the Placement Agents with respect to all FINRA filings that the Company or the Placement Agents may be required
to make and provide all information and documentation necessary to make the filings in a timely manner The Company will pay all
expenses related to all FINRA filings that the Company or Placement Agents may be required to make, including, but not limited
to, all printing costs related to all documents required or that the Agent may reasonably deem necessary, to comply with FINRA
rules; any FINRA filing fees; postage and express charges; and all other expenses incurred in making the FINRA filings.

 

The Company agrees and
understands that this Agreement in no way constitutes a guarantee that the Offering will be successful. The Company acknowledges
that the Company is ultimately responsible for the successful completion of a transaction.

 

7.           Conditions
of the Company’s Obligations. The obligations of the Company hereunder are subject to the satisfaction of each of
the following conditions:

 

(a)          The
satisfaction or waiver of all conditions to Closing as set forth herein.

 

(b)          As
of each Closing, each of the representations and warranties made by Placement Agents herein being true and correct as of the Closing
Date for such Closing.

 

(c)          At
each Closing, the Company shall have received the proceeds from the sale of the Securities that are part of such Closing less applicable
Broker Fees and other deductions contemplated by this Agreement.

 

(d)          At
each Closing, the Company shall have received a copy of Subscription Documents signed by investors delivered by the Placement Agents.

 

7A.         Mutual
Condition. The obligations of the Placement Agents and the Company hereunder are subject to the execution by each investor
of a Subscription Agreement in form and substance acceptable to the Placement Agents and the Company and deposit by such investor
with the escrow agent of all funds required to be so deposited by such investor.

 

8.           Indemnification.

 

(a)          The
Company will: (i) indemnify and hold harmless the Placement Agents, jointly and severally, their agents and their respective officers,
directors, employees, agents, selected dealers and each person, if any, who controls the Placement Agents within the meaning of
the Act and such agents (each an “Indemnitee” or a “Placement Agent Party”) against, and pay or reimburse
each Indemnitee for, any and all losses, claims, damages, liabilities or expenses whatsoever (or actions or proceedings or investigations
in respect thereof (collectively, “Proceedings”), joint or several (which will, for all purposes of this Agreement,
include, but not be limited to, all reasonable costs of defense and investigation and all reasonable attorneys’ fees, including
appeals), to which any Indemnitee may become subject (a) under the Act or otherwise, in connection with the offer and sale of the
Securities and (b) as a result of the breach of any representation, warranty or covenant made by the Company herein or the failure
of the Company to perform its obligations under the Agreement, regardless of whether such losses, claims, damages, liabilities
or expenses shall result from any claim by any Indemnitee or by any third party; and (ii) reimburse each Indemnitee for any legal
or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, action, proceeding
or investigation; provided, however, the Company will not be liable in any such case to the extent that any such claim, damage
or liability of a Placement Agent is to have resulted from that Placement Agent’s gross negligence or willful misconduct.
In addition to the foregoing agreement to indemnify and reimburse, the Company will indemnify and hold harmless each Indemnitee
against any and all losses, claims, damages, liabilities or expenses whatsoever (or actions or proceedings or investigations in
respect thereof), joint or several (which shall, for all purposes of this Agreement, include, but not be limited to, all reasonable
costs of defense and investigation and all reasonable attorneys’ fees, including appeals) to which any Indemnitee may become
subject insofar as such costs, expenses, losses, claims, damages or liabilities arise out of or are based upon the claim of any
person or entity that he or it is entitled to broker’s or finder’s fees from any Indemnitee in connection with the
Offering as a result of the Company obligating itself or any Indemnitee to pay such a fee, other than fees due to the Placement
Agents, its dealers, sub-agents or finders. The foregoing indemnity agreements will be in addition to any liability the Company
may otherwise have. The Indemnitees are intended third party beneficiaries of this provision.

 

    	 

    	 

    

 

(b)          Promptly
after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, claim, proceeding or investigation
(the “Action”), such indemnified party, if a claim in respect thereof is to be made against the indemnifying party
under this Section 8, will notify the indemnifying party of the commencement thereof, but the omission to so notify the indemnifying
party will not relieve it from any liability that it may have to any indemnified party under this Section 8 unless the indemnifying
party has been substantially prejudiced by such omission. The indemnifying party will be entitled to participate in and, to the
extent that it may wish, jointly with any other indemnifying party, to assume the defense thereof subject to the provisions herein
stated, with counsel reasonably satisfactory to such indemnified party. The indemnified party will have the right to employ separate
counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel will not be at
the expense of the indemnifying party if the indemnifying party has assumed the defense of the Action with counsel reasonably satisfactory
to the indemnified party, provided, however, that if the indemnified party shall be requested by the indemnifying party to participate
in the defense thereof or shall have concluded in good faith and specifically notified the indemnifying party either that there
may be specific defenses available to it that are different from or additional to those available to the indemnifying party or
that such Action involves or could have a material adverse effect upon it with respect to matters beyond the scope of the indemnity
agreements contained in this Agreement, then the counsel representing it, to the extent made necessary by such defenses, shall
have the right to direct such defenses of such Action on its behalf and in such case the reasonable fees and expenses of such counsel
in connection with any such participation or defenses shall be paid by the indemnifying party. No settlement of any Action against
an indemnified party will be made without the consent of the indemnifying party and the indemnified party, which consent shall
not be unreasonably withheld or delayed in light of all factors of importance to such party, and no indemnifying party shall be
liable to indemnify any person for any settlement of any such claim effected without such indemnifying party’s consent. Notwithstanding
the immediately preceding sentence, if at any time an indemnified party requests the indemnifying party to reimburse the indemnified
party for legal or other expenses in connection with investigating, responding to or defending any Proceedings as contemplated
by this indemnity agreement, the indemnifying party will be liable for any settlement of any Proceedings effected without its written
consent if (i) the proposed settlement is entered into more than 30 days after receipt by the indemnifying party of the request
for reimbursement, (ii) the indemnifying party has not reimbursed the indemnified party within 30 days of such request for reimbursement,
(iii) the indemnified party delivered written notice to the indemnifying party of its intention to settle and the failure to pay
within such 30 day period, and (iv) the indemnifying party does not, within 15 days of receipt of the notice of the intention to
settle and failure to pay, reimburse the indemnified party for such legal or other expenses and object to the indemnified party’s
seeking to settle such Proceedings.

 

    	 

    	 

    

 

9.           Contribution.
To provide for just and equitable contribution, if: (i) an indemnified party makes a claim for indemnification pursuant to Section
8 hereof and it is finally determined, by a judgment, order or decree not subject to further appeal that such claims for indemnification
may not be enforced, even though this Agreement expressly provides for indemnification in such case; or (ii) any indemnified
or indemnifying party seeks contribution under the Act, the Exchange Act, or otherwise, then each indemnifying party shall contribute
to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative
benefits but also the relative fault of the Company on the one hand and the Placement Agents on the other in connection with the
statements or omissions which resulted in such losses, claims, damages, liabilities or expenses (or actions in respect thereof),
as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Placement
Agents on the other shall be deemed to be in the same proportion as the total net proceeds from the Offering (before deducting
expenses) received by the Company bear to the total Brokers’ Fees received by the Placement Agents. The relative fault, in
the case of an untrue statement, alleged untrue statement, omission or alleged omission will be determined by, among other things,
whether such statement, alleged statement, omission or alleged omission relates to information supplied by the Company or by the
Placement Agents, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement, alleged statement, omission or alleged omission. The Company and the Placement Agents agree that it would be unjust
and inequitable if the respective obligations of the Company and the Placement Agents for contribution were determined by pro rata
allocation of the aggregate losses, liabilities, claims, damages and expenses or by any other method or allocation that does not
reflect the equitable considerations referred to in this Section 9. No person guilty of a fraudulent misrepresentation (within
the meaning of Section 10(f) of the Act) will be entitled to contribution from any person who is not guilty of such fraudulent
misrepresentation. For purposes of this Section 9, each person, if any, who controls the Placement Agents within the meaning of
the Act will have the same rights to contribution as the Placement Agents, and each person, if any, who controls the Company within
the meaning of the Act will have the same rights to contribution as the Company, subject in each case to the provisions of this
Section 9. Anything in this Section 9 to the contrary notwithstanding, no party will be liable for contribution with respect to
the settlement of any claim or action effected without its written consent. This Section 9 is intended to supersede, to the extent
permitted by law, any right to contribution under the Act, the Exchange Act or otherwise available. The provisions of Section 9
shall apply to each Placement Agent on a several, and not joint, basis.

 

10.         Termination.

 

(a)          The
Offering may be terminated by the Placement Agents at any time prior to the expiration of the Offering Period in the event that:
(i) any of the representations, warranties or covenants of the Company contained herein or in the Subscription Documents shall
prove to have been false or misleading in any material respect when actually made; (ii) the Company shall have failed to perform
any of its material obligations hereunder or under any other Company Transaction Document or any other transaction document; (iii)
there shall occur any event, within the control of the Company that is reasonably likely to materially and adversely affect the
transactions contemplated hereunder or the ability of the Company to perform hereunder; or (iv) the Placement Agents determine
that it is reasonably likely that any of the conditions to Closing to be fulfilled by the Company set forth herein will not, or
cannot, be satisfied.

 

    	 

    	 

    

 

(b)          This Offering
may be terminated by the Company at any time prior to the Termination Date in the event that (i) the Placement Agents shall
have failed to perform any of its material obligations hereunder or (ii) on account of the Placement Agents’ fraud, illegal
or willful misconduct or gross negligence. In the event of any termination by the Company, the Placement Agents shall be entitled
to receive, on the Termination Date, all unpaid Broker Fees earned or accrued through the Termination Date and reimbursement of
all expenses as provided for in this Agreement, but shall be entitled to no other amounts whatsoever except as may be due under
any indemnity or contribution obligation for provided herein, at law or otherwise. On such Termination Date, the Company shall
pay all such unpaid costs and expenses incurred by the Placement Agents in connection with the Offering; provided, however,
that such costs and expenses shall not exceed the maximum Placement Agent Expense Allowance, and all unpaid Blue Sky Fees and other
expenses set forth in Section 5(i) hereof.

 

(c)          This
Offering may be terminated upon mutual agreement of the Company and the Placement Agents at any time prior to the expiration of
the Offering Period.

 

(d)          Except
as otherwise provided above, before any termination by the Placement Agents under Section 10(a) or by the Company under Section
10(b) shall become effective, the terminating party shall give ten (10) day prior written notice to the other party of its intention
to terminate the Offering (the “Termination Notice”). The Termination Notice shall specify the grounds for the proposed
termination. If the specified grounds for termination, or their resulting adverse effect on the transactions contemplated hereby,
are curable, then the other party shall have five (5) days from the Termination Notice within which to remove such grounds or to
eliminate all of their material adverse effects on the transactions contemplated hereby; otherwise, the Offering shall terminate.

 

(e)          Upon
any termination pursuant to this Section 10, the Placement Agents and the Company will instruct the Escrow Agent to cause all monies
received with respect to the subscriptions for Securities not accepted by the Company to be promptly returned to such subscribers
without interest, penalty or deduction.

 

11.         Survival.

 

(a)          The
obligations of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided
herein shall survive any termination hereunder. In addition, the provisions of Sections 3, and 8 through 22 shall survive the sale
of the Securities or any termination of the Offering hereunder.

 

(b)          The
respective indemnities, covenants, representations, warranties and other statements of the Company and the Placement Agents set
forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of, and regardless of any access to information by the Company or the Placement Agents, or any of their officers or directors
or any controlling person thereof, and will survive the sale of the Securities or any termination of the Offering hereunder.

 

12.         Notices.
All notice and other communications hereunder will be in writing and shall be deemed effectively given to a party by (a) personal
delivery; (b) upon deposit with the United States Post Office, by certified mail, return receipt requested, first-class mail, postage
prepaid; (c) delivered by hand or by messenger or overnight courier, addressee signature required, to the addresses below or at
such other address and/or to such other persons as shall have been furnished by the parties:

 

	If to the Company:	Danlax Corp
	 	2360 Corporate Circle
	 	Suite 400
	 	Henderson, NV  89074-7722
	 	 
	With a copy to:	CKR Law LLP
	(which shall not constitute notice)	1330 Avenue of the Americas, 35th floor
	 	New York, NY 10019
	 	Attention: Barrett S. diPaolo, Esq.

 

 

    	 

    	 

    

 

	If to Northland Securities, Inc.:  	Northland Securities, Inc.
	 	45 South 7th Street
	 	Minneapolis, MN  55402
	 	Attention:  Mr. Jeffrey Peterson
	 	Director of Investment Banking
	 	 
	With a copy to:	Faegre Baker Daniels LLP
	(which shall not constitute notice)	2200 Wells Fargo Center
	 	90 South Seventh Street
	 	Minneapolis, MN  55402-3901
	 	Attention: Jonathan R. Zimmerman, Esq.
	 	 
	If to Katalyst Securities, LLC.	Katalyst Securities, LLC
	 	15 Maiden Lane, Room 601
	 	New York, NY 10038
	 	Attention:  Paul Ehrenstein
	 	President
	 	 
	With a copy to:	Barbara J. Glenns, Esq.
	(which shall not constitute notice)	Law Office of Barbara J. Glenns, Esq.
	 	30 Waterside Plaza, Suite 25G
	 	New York, NY 10010

 

13.          Governing
Law, Jurisdiction. This Agreement shall be deemed to have been made and delivered in New York City and shall be governed
as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of New York without
regard to principles of conflicts of law thereof.

 

THE
PARTIES HERETO AGREE TO SUBMIT ALL CONTROVERSIES TO the exclusive jurisdiction of finra ARBITRATION IN ACCORDANCE WITH THE PROVISIONS
SET FORTH BELOW AND UNDERSTAND THAT (A) ARBITRATION IS FINAL AND BINDING ON THE PARTIES, (B) THE PARTIES ARE WAIVING THEIR RIGHTS
TO SEEK REMEDIES IN COURT, INCLUDING THE RIGHT TO A JURY TRIAL, (C) PRE-ARBITRATION DISCOVERY IS GENERALLY MORE LIMITED AND DIFFERENT
FROM COURT PROCEEDINGS, (D) THE ARBITRATOR’S AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDINGS OR LEGAL REASONING AND ANY
PARTY’S RIGHT TO APPEAL OR TO SEEK MODIFICATION OF RULES BY ARBITRATORS IS STRICTLY LIMITED, (E) THE PANEL OF FINRA ARBITRATORS
WILL TYPICALLY INCLUDE A MINORITY OF ARBITRATORS WHO WERE OR ARE AFFILIATED WITH THE SECURITIES INDUSTRY, AND (F) ALL CONTROVERSIES
WHICH MAY ARISE BETWEEN THE PARTIES CONCERNING THIS AGREEMENT SHALL BE DETERMINED BY ARBITRATION PURSUANT TO THE RULES THEN PERTAINING
TO FINRA. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEw york. JUDGMENT ON ANY AWARD OF ANY SUCH ARBITRATION
MAY BE ENTERED IN THE SUPREME COURT OF THE STATE OF NEW YORK OR IN ANY OTHER COURT HAVING JURISDICTION OVER THE PERSON OR PERSONS
AGAINST WHOM SUCH AWARD IS RENDERED. THE PARTIES AGREE THAT THE DETERMINATION OF THE ARBITRATORS SHALL BE BINDING AND CONCLUSIVE
UPON THEM. THE PREVAILING PARTY, AS DETERMINED BY SUCH ARBITRATORS, IN A LEGAL PROCEEDING SHALL BE ENTITLED TO COLLECT ANY COSTS,
DISBURSEMENTS AND REASONABLE ATTORNEY’S FEES FROM THE OTHER PARTY.  PRIOR TO FILING AN ARBITRATION, THE PARTIES
HEREBY AGREE THAT THEY WILL ATTEMPT TO RESOLVE THEIR DIFFERENCES FIRST BY SUBMITTING THE MATTER FOR RESOLUTION TO A MEDIATOR, ACCEPTABLE
TO ALL PARTIES, AND WHOSE EXPENSES WILL BE BORNE EQUALLY BY ALL PARTIES. THE MEDIATION WILL BE HELD IN THE COUNTY OF NEW YORK,
STATE OF NEW YORK, ON AN EXPEDITED BASIS. IF THE PARTIES CANNOT SUCCESSFULLY RESOLVE THEIR DIFFERENCES THROUGH MEDIATION, THE MATTER
WILL BE RESOLVED BY ARBITRATION. THE ARBITRATION SHALL TAKE PLACE IN THE COUNTY OF NEW YORK, THE STATE OF NEW YORK, ON AN EXPEDITED
BASIS. 

 

    	 

    	 

    

 

14.          Miscellaneous.

 

(a)          No
provision of this Agreement may be changed or terminated except by a writing signed by the party or parties to be charged therewith.
Unless expressly so provided, no party to this Agreement will be liable for the performance of any other party’s obligations
hereunder. Either party hereto may waive compliance by the other with any of the terms, provisions and conditions set forth herein;
provided, however, that any such waiver shall be in writing specifically setting forth those provisions waived thereby. No such
waiver shall be deemed to constitute or imply waiver of any other term, provision or condition of this Agreement. Neither party
may assign its rights or obligations under this Agreement to any other person or entity without the prior written consent of the
other party.

 

(b)          Each
party shall, without payment of any additional consideration by any other party, at any time on or after the date of any Closings,
take such further action and execute such other and further documents and instruments as the other party may reasonably request
in order to provide the other party with the benefits of this Agreement.

 

(c)          The
Parties to this Agreement each hereby confirm that they will cooperate with each other to the extent that it may become necessary
to enter into any revisions or amendments to this Agreement, in the future to conform to any federal or state regulations as long
as such revisions or amendments do not materially alter the obligations or benefits of either party under this Agreement.

 

15.          Entire
Agreement; Severability. This Agreement together with any other agreement referred to herein supersedes all prior understandings
and written or oral agreements between the parties with respect to the Offering and the subject matter hereof. If any portion of
this Agreement shall be held invalid or unenforceable, then so far as is reasonable and possible (i) the remainder of this Agreement
shall be considered valid and enforceable and (ii) effect shall be given to the intent manifested by the portion held invalid or
unenforceable.

 

16.          Counterparts.
This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties and shall
be deemed to be an original instrument which shall be enforceable against the parties actually executing such counterparts and
all of which together shall constitute one and the same instrument. The exchange of copies of this Agreement and of signature pages
by facsimile transmission or in pdf format shall constitute effective execution and delivery of this Agreement as to the parties
and may be used in lieu of the original Agreement for all purposes. Signatures of the parties transmitted by facsimile or in pdf
format shall be deemed to be their original signatures for all purposes.

 

17.          Announcement
of Offering. The Placement Agents and their counsel and advisors may, subsequent to the closing of any Offering,
make public their involvement with the Company, including use of the Company’s trademarks and logos. The Placement Agents
counsel and advisors are intended third party beneficiaries of this Section.

 

    	 

    	 

    

 

18.          Advice
to the Board. The Company acknowledges that any advice given by the Placement Agents to the Company is solely for benefit
and use of the Company’s board of directors and officers, who will make all decisions regarding whether and how to pursue
any opportunity or transaction, including any potential Offering. The Company’s board of directors and management may consider
such advice, but will also base their decisions on the advice of legal, tax and other business advisors and other factors which
they consider appropriate. Accordingly, as an independent contractor, the Placement Agents will not assume the responsibilities
of a fiduciary to the Company or its stockholders in connection with the performance of the services. Any advice provided may not
be used, reproduced, disseminated, quoted or referred to without prior written consent of the providing party. The Placement Agents
do not provide accounting, tax or legal advice. The Company is a sophisticated business enterprise that has retained the Placement
Agents for the limited purposes set forth in this Agreement. The parties acknowledge and agree that their respective rights and
obligations are contractual in nature. Each party disclaims an intention to impose fiduciary obligations on the other by virtue
of the engagement contemplated by this Agreement.

 

19.          Other
Investment Banking Services. The Company acknowledges that the Placement Agents and their affiliates are securities firms
engaged in securities trading and brokerage activities and providing investment banking and financial advisory services. In the
ordinary course of business, the Placement Agents and their affiliates may at any time hold long or short positions, and may trade
or otherwise effect transactions, for their own account or the accounts of customers, in the Company’s debt or equity securities,
its affiliates or other entities that may be involved in the transactions contemplated by this Agreement. In addition, the Placement
Agents and their affiliates may from time to time perform various investment banking and financial advisory services for other
clients and customers who may have conflicting interests with respect to the Company or the Offering. The Company also acknowledges
that the Placement Agents and their affiliates have no obligation to use in connection with this engagement or to furnish the Company,
confidential information obtained from other companies. Furthermore, the Company acknowledges the Placement Agents may have fiduciary
or other relationships whereby their or their affiliates may exercise voting power over securities of various persons, which securities
may from time to time include securities of the Company or others with interests in respect of any Offering. The Company acknowledges
that the Placement Agents or such affiliates may exercise such powers and otherwise perform our functions in connection with such
fiduciary or other relationships without regard to the Placement Agents’ relationship to the Company hereunder.

 

20.          Research
Matters. By entering into this Agreement or serving as a placement agent
in the Offering, the Placement Agents do not provide any promise, either explicitly or implicitly, of favorable or continued research
coverage of the Company and the Company hereby acknowledges and agrees that the Placement Agents’ selection as a placement
agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agents providing favorable or any
research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties acknowledge and agree that the Placement Agents
have not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change
research, a rating or a price target, to the Company or inducement for the receipt of business or compensation.

 

21.          Successors.
This Agreement shall inure to the benefit of and be binding upon the successors of the Placement Agents and of the Company
(including any party that acquires the Company or all or substantially all of its assets or merges with the Company). Nothing expressed
or mentioned in this Agreement is intended or shall be construed to give any person or corporation, other than the parties hereto
and parties expressly referred to herein, any legal or equitable right, remedy or claim under or in respect to this Agreement or
any provision hereof. The term “successors” shall not include any purchaser of the Securities merely by reason of such
purchase. No subrogee of a benefited party shall be entitled to any benefits hereunder. Each party hereto disclaims any an intention
to impose any fiduciary obligation on any other party by virtue of the arrangements contemplated by this Agreement.

 

    	 

    	 

    

 

22.          Future
Services. In the event the Company determines to undertake any public offering, any private offering of securities or any
merger, acquisition or sale transaction, whether on its own behalf or on behalf of its security holders, at any time within the
Offering Period or within two years thereafter, the Company will offer Northland the right to serve as sole bookrunner (in the
case of a public offering), as placement agent (in the case of a private or registered direct offering) or as financial advisor
(in the case of a merger, acquisition or sale transaction). At the Company’s request, Northland shall agree to act as a co-agent
with another agent for the aforementioned public offering, private offering, or merger, acquisition or sale transaction, provided
that (a) Northland shall remain the sole bookrunner in the case of a public offering; and (b) Northland shall be entitled to (i)
no less than 50% of the total allocation of the securities to the agents or underwriters and (ii) no less than its pro rata portion
of the discounts, commissions or fees to the agents or underwriters, based on the percentage of the total offering that Northland
actually places or underwrites. If Northland agrees to act in such capacity, the Company and Northland will enter into an appropriate
form of separate agreement containing customary terms and conditions to be mutually agreed upon. This Agreement is neither an expressed
nor implied commitment by Northland to act in any capacity in any such transaction or to purchase any securities in connection
therewith, which commitment will only be set forth in a separate agreement. Notwithstanding the foregoing, in no event shall the
right provided by this Section have a duration of more than three years from the date of effectiveness or commencement of sales
of the Offering.

 

[Signatures on following page.]

 

    	 

    	 

    

 

If the foregoing is
in accordance with your understanding of the agreement among the Company and the Placement Agents, kindly sign and return this
Agreement, whereupon it will become a binding agreement as provided herein, between the Company and the Placement Agents in accordance
with its terms.

 

This Agreement contains
a predispute arbitration provision in paragraph 13.

 

	 	 	DANLAX CORP.
	 	 	 
	 	 	By:	/s/ Ivan Krikun
	 	 	 	 	Ivan Krikun
	 	 	 	 	Chief Executive Officer
	 	 	 	 
	 	 	Northland SECURITIES, INC.
	 	 	 	 
	 	 	By:	        /s/ Jeffrey Peterson
	 	 	 	 	Jeffrey Peterson
	 	 	 	 	Head of Investment Banking
	 	 	 	 
	 	 	KATALYST SECURITIES LLC
	 	 	 	 
	 	 	By:	/s/ Michael A. Silverman
	 	 	 	 	Michael A. Silverman
	 	 	 	 	Managing Director

 

    	 

    	 

    

 

Attachment
I

FORM
OF BROKER WARRANT

 

[See Exhibit 10.8]

 

    	 

    	 

    

Attachment
II

 

FORM OF LEGAL OPINION

 

1.          The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada. Each subsidiary
of the Company is duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation or
formation.

 

2.          The
Company and each subsidiary has all necessary corporate power and authority to (i) execute and deliver, and to perform its obligations
under, the Subscription Documents and the Placement Agency Agreement and (ii) conduct its business as it is, to our knowledge,
currently conducted and described in the Company SEC Documents, and own, lease and license its properties and assets.

 

3.          The
Company is duly qualified to do business and is in good standing as a foreign corporation in each jurisdiction in which the nature
of the business conducted or property owned by it makes such qualification necessary except where the failure to be so qualified
and in good standing would not result in a Company Material Adverse Effect.

 

4.          The
execution, delivery and performance by the Company of the Subscription Documents and the Placement Agency Agreement and the consummation
of the transactions contemplated thereby, including the issuance of the Securities, the Brokers Warrants and the Brokers Warrant
Shares, have been duly authorized by all necessary corporate action of the Company.

 

5.          The
Subscription Documents and the Placement Agency Agreement have been duly executed and delivered by the Company and constitute the
legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to
applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance and similar laws in effect from time to time
and general equitable principles.

 

6.          Except
for filings, authorizations or approvals contemplated by the Subscription Documents and the Placement Agency Agreement, no authorizations
or approvals of, and no filings with, any governmental or administrative agency, regulatory authority, stock market or trading
facility are necessary or required by the Company for the execution and delivery of the Subscription Documents or the Placement
Agency Agreement or the consummation of the transactions contemplated thereby.

 

7.          Neither
the execution and delivery of the Subscription Documents or the Placement Agency Agreement by the Company, nor the consummation
or performance by the Company of any of the transactions contemplated thereby (including the issuance of the Securities, the Brokers
Warrants and the Brokers Warrant Shares) (i) contravene, conflict with or result in a violation of any provisions of the Company’s
certificate of incorporation or bylaws; (ii) constitute a violation of any U.S. federal or state law, rule or regulation applicable
to the Company; (iii) violate any judgment, decree, order or award of any court, governmental body or arbitrator specifically naming
the Company; or (iv) with or without notice and/or the passage of time, conflict with or result in the breach or termination of
any term or provision of, or constitute a default under, or cause any acceleration under, or cause the creation of any lien, charge
or encumbrance upon the properties or assets of the Company or its subsidiaries pursuant to, any agreement to which the Company
or its subsidiaries is a party (including those described or included in the Company’s SEC Filings).

 

8.          The
authorized capital stock of the Company on the date hereof consists of [________] shares of Common Stock and [______] shares of
preferred stock, [_____] of which are designated as [_________] Preferred Stock. As of the date hereof, without giving effect to
the sale of securities contemplated by the Subscription Documents and the Placement Agency Agreement to occur at the Closing, there
are issued and outstanding of record: [___________] shares of Common Stock and no shares of preferred stock. There are issued and
outstanding of record warrants and options to purchase [_________] shares of Common Stock. The currently outstanding shares
of capital stock of the Company have been duly authorized and validly issued and are fully paid and nonassessable. The form of
certificates for the Shares and the Brokers Warrant Shares conforms
to the requirements of Delaware law. The capital stock of the Company conforms as to legal matters to the description thereof contained
in the Company’ SEC Filings.

 

    	 

    	 

    

 

9.          To
our knowledge, except as provided or disclosed in the Company’s SEC Filings, no person or entity is entitled to any preemptive,
right of first refusal, contractual or similar rights with respect to the issuance of the Securities, the Brokers Warrants or the
Brokers Warrant Shares.

 

10.         The
Securities, the Brokers Warrants and the Brokers Warrant Shares have been duly authorized or reserved for issuance by all necessary
corporate action on the part of the Company; and the Securities, when issued, sold and delivered against payment therefor in accordance
with the provisions of the Subscription Documents, and the Brokers Warrants Shares, when issued upon exercise of the Brokers Warrants
in accordance with the terms thereof, will be duly and validly issued, fully paid and non-assessable. The board of directors of
the Company has adopted a resolution reserving Common Stock issuable upon exercise of the Brokers Warrants.

 

11.         Assuming
the accuracy of the representations and warranties of each of the investors set forth in the Subscription Documents and of the
Company set forth in the Placement Agency Agreement, the offer, issuance and sale of the Securities at the Closing pursuant to
the Subscription Documents and the issuance of the Brokers Warrants pursuant to the Placement Agency Agreement are, and the issuance
of the Brokers Warrant Shares issuable upon exercise of the Brokers Warrants will be exempt from the registration requirements
of the Securities Act and the securities or “blue sky” laws of any state.

 

12.         Other
than as disclosed in the Company’s SEC Filings, we are not aware of any actions, suits, arbitrations, claims, proceedings
or investigations pending or threatened against the Company or its subsidiaries or any of their respective operations, businesses,
properties or assets by or before any court, arbitrator or government or regulatory commission, board, body, authority or agency
that challenges the validity of any actions taken or to be taken by the Company pursuant to the Subscription Documents or the Placement
Agency Agreement or the transaction contemplated thereby.

 

13.         To
our knowledge and except as set forth in the Company’s SEC Filings, no holders of the Company’s securities have rights
to the registration of shares of Common Stock or other securities of the Company because of the Offering or the issuance of the
Securities, Brokers Warrants or the Brokers Warrant Shares.

 

14.         The
descriptions in the Company’s SEC Filings of statutes, regulations, legal and governmental proceedings, contracts and other
documents are accurate and fairly present the information required to be shown; and we are not aware of any statutes, regulations,
legal or governmental proceedings or contracts or other documents required to be described in the Company’s SEC Filings or
included as exhibits to the Company’s SEC Filings that are not described or included as required.

 

15.         Nothing
has come to our attention that has caused us to be aware that any of the Company’s SEC Filings contained an untrue statement
of a material fact or omitted to state a material fact necessary to make the statements therein, in light of the circumstances
in which they were made, not misleading. We do not express any belief as to the financial statements and related notes, financial
statement schedules or financial or accounting data and information contained in or omitted from the Company’s SEC Filings.Exhibit 10.7

 

FIRST AMENDMENT 

 

This First Amendment
to Placement Agency Agreement (“Amendment”) is entered into as of the 15th day of May 2015, by and among
Akoustis Technologies, Inc. (formerly known as Danlax Corp., the “Company”), Northland Securities, Inc. (“Northland”)
and Katalyst Securities Inc. (“Katalyst”), (collectively referred to as the “Placement Agents”) and amends
the Placement Agency Agreement dated April 17, 2015 (the “Agreement”).

 

The Parties to the Agreement hereby amend
and restate in its entirety the following paragraphs of the Agreement to read as follows:

 

Paragraph 1 (a):

 

(a)On the basis of
the written and documented representations and warranties of the Company provided herein, and subject to the terms and conditions
set forth herein, the Placement Agents are hereby appointed as co-exclusive Placement Agents of the Company during the Offering
Period (as defined in Section 3(b) below) to assist the Company in finding qualified subscribers for the Offering. The Placement
Agents may sell the Securities through other broker-dealers who are FINRA members (collectively, the “Sub Agents”)
and may reallow all or a portion of the Brokers’ Fees (as defined in Section 3(a), 3(b) and 3(d) below) it receives to such
other Sub Agents or pay a finders or consultant fee as allowed by applicable law. On the basis of such representations and warranties
and subject to such terms and conditions, the Placement Agents hereby accept such appointment and agree to perform the services
hereunder diligently and in good faith and in a professional and businesslike manner and in compliance with applicable law and
to use its reasonable best efforts to assist the Company in finding subscribers of the Securities who qualify as “accredited
investors,” as such term is defined in Rule 501 of Regulation D. The Placement Agents have no obligation to purchase any
of the Securities or sell any Securities. Unless sooner terminated in accordance with this Agreement, the engagement of the Placement
Agents hereunder shall continue until the later of the Termination Date or the Final Closing (as defined below). The Offering is
currently anticipated to be the private placement of a minimum of gross proceeds of $3,000,000 (the “Minimum Offering”)
and a maximum of gross proceeds of $6,000,000 through the sale of Four Million (4,000,000) shares (the “Maximum Offering”)
through the sale of shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), at the
Purchase Price of $1.50 per share (the “Offering Price”). The minimum subscription is $90,000 (60,000 shares), provided,
however, that subscriptions in lesser amounts may be accepted by the Company in its sole discretion.

 

This Amendment is hereby
made part of and incorporated into the Agreement, with all the terms and conditions of the Agreement remaining in full force and
effect, except to the extent modified hereby.

 

This Amendment may
be executed in multiple counterparts, each of which may be executed by less than all of the parties and shall be deemed to be an
original instrument which shall be enforceable against the parties actually executing such counterparts and all of which together
shall constitute one and the same instrument. The exchange of copies of this Amendment and of signature pages by facsimile transmission
or in pdf format shall constitute effective execution and delivery of this Amendment as to the parties and may be used in lieu
of the original Amendment for all purposes. Signatures of the parties transmitted by facsimile or in pdf format shall be deemed
to be their original signatures for all purposes.

 

    	1

    	 

    

 

IN WITNESS WHEREOF, this Amendment
has been executed and delivered by the parties below effective as of the date first set forth above.

 

	 	DANLAX CORP.
	 	 	 
	 	By:	/s/
    Ivan Krikun
	 	 	Ivan Krikun
	 	 	Chief Executive Officer
	 	 	 
	 	Northland
    SECURITIES, INC.
	 	 	 
	 	By:	/s/
    Jeffrey Peterson
	 	 	Jeffrey Peterson
	 	 	Head of Investment Banking
	 	 	 
	 	KATALYST SECURITIES
    LLC
	 	 	 
	 	By:	/s/
    Michael A. Silverman
	 	 	Michael A. Silverman
	 	 	Managing Director

 

    	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]